Retatrutide/Cagrilitide 10 mg + 5 mg product image
All Products, Peptides, Powders, Weight Loss

Retatrutide/Cagrilitide 10 mg + 5 mg

Retatrutide / Cagrilitide 10 mg + 5 mg research-grade lyophilized powder supplied in a sealed glass vial. This dual-compound formulation is studied in experimental mod...

Retatrutide/Cagrilitide 10 mg + 5 mg Product Information

Retatrutide / Cagrilitide 10 mg + 5 mg research-grade lyophilized powder supplied in a sealed glass vial. This dual-compound formulation is studied in experimental models of metabolic regulation, appetite signaling and energy balance via incretin and amylin-related pathways. Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use. Purity High-purity research grade Form Lyophilized powder Content Retatrutide 10 mg + Cagrilitide 5 mg (15 mg total) per vial Total content 15 mg combined lyophilized peptide Packaging Sealed glass vial with sterile stopper Storage Store in a cool, dry place. Recommended storage below 18 °C. Molecular formula Not specified (peptide compounds) Molecular weight Not specified (peptide compounds) IUPAC name Retatrutide; Cagrilitide CAS number Retatrutide: 2381089-83-2 Cagrilitide: 1415456-99-3 Research Overview Retatrutide and cagrilitide are synthetic peptide analogues studied in advanced metabolic research. Retatrutide is investigated for its multi-receptor activity within incretin pathways, while cagrilitide is explored as a long-acting amylin analogue. In experimental settings, this combination is used to study appetite regulation, energy expenditure, glucose handling and metabolic signaling integration. Primary Research Areas Incretin & amylin signaling pathways: used to investigate combined modulation of GLP-1, GIP, glucagon and amylin-related receptor systems in metabolic research models. Energy balance & appetite regulation: applied in experimental studies examining food intake behavior, satiety signaling and central–peripheral metabolic communication. Glucose metabolism & insulin dynamics: explored in preclinical models assessing glycemic control, insulin sensitivity and pancreatic signaling responses. Body-weight regulation models: studied in animal models of obesity and metabolic dysfunction to evaluate synergistic effects on adiposity and energy expenditure. Neuroendocrine & metabolic integration: investigated for interactions between central appetite circuits, peripheral hormone signaling and adaptive metabolic responses.